<DOC>
	<DOC>NCT01775293</DOC>
	<brief_summary>The aim of this study is to evaluate the efficacy and safety of the investigational device, RPM,non-absorbable polypropylene mesh made by D Med, in correction of Nasolabial fold. Study hypothesis - level of significance: alpha=0.05( two-side) - power of test: (power= 1-beta),power=0.08 - H0: P equals P0 - H1: P unequals P0 - The difference between the changes in the WSRS(Wrinkle Severity Rating Scale) of the pre and post rhytidectomy from baseline at 7week after administration is 0.237( P-P0= 0.237)</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Efficacy and Safety in Nasolabial Fold After Rhytidectomy Using Non-absorbable Mesh</brief_title>
	<detailed_description>1. Benefits - enhancing self-satisfaction and quality of life by improving skin elasticity and correcting folds in the nasolabial fold area 2. Risks - erythema, swelling, pain and redness in the facial area generally resolve in 1 week 3.Duration of study - entire duration: approximate 36weeks - Follow-up period: 7 weeks - Enrollment period: 12 weeks 4. study design - 2 step operation process - First step- insert polypropylene mesh under the skin - Second step- pull the polypropylene mesh 3 weeks later</detailed_description>
	<criteria>Subjects who had soft tissue sagging around nasolabial fold Female aged between 30 and 65, having grade 3 or 4 of nasolabial fold as Wrinkle severity Rating Scale(WSRS) Subjects who voluntary decided to participate in the study and signed the informed consent Subjects who have a skin disease on the face Subjects who have severe facial skin disease Subjects who are constantly taking anticoagulants including aspirin Subjects who have too thin or thick skin Subjects who have a systemic disease such as uncontrolled high blood pressure, diabetes, heart disease Subjects who had an allergy to nonabsorbable material. Subjects who are taking immune suppressants General weakness status Pregnant or lactating women Subjects who have an asthma, cancer, AIDS, Cystic fibrosis, Immobility cilia syndrome, leukopenia, Immunoglobulin deficiency, active infectious disease, serious liver or renal disease, Subjects who had a history of dermal augmentation surgery with permanent implants(e.g. silicone, SoftformÂ®)on the face Subjects who participated in other clinical trial within 30 days from screening</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Non-absorbable polypropylene mesh</keyword>
	<keyword>WSRS</keyword>
	<keyword>Rhytidectomy</keyword>
</DOC>